Substituted naphthalen-1-yl-acetic acid hydrazides: synthesis, antimicrobial evaluation and QSAR analysis. 2013

Rakesh Narang, and Balasubramanian Narasimhan, and Sunil Sharma, and Erik De Clercq, and Christophe Pannecouque, and Jan Balzarini
Department of Pharmaceutical Sciences, Guru Jmabheshwar University of Science and Technology, Hisar 125001, India.

A series of naphthalen-1-yl-acetic acid benzylidene/(1-phenyl-ethylidene)-hydrazides (1-36) was synthesized and tested, in vitro, for antiviral, antibacterial and antifungal activities. The antibacterial and antifungal screening results indicated that compounds having o-bromo, methoxy and hydroxy substitutents were the most active ones. The results of antiviral evaluation showed that none of the synthesized derivatives inhibited the viral infection at subtoxic concentrations. QSAR investigations revealed that the multi-target QSAR model was more effective in describing the antimicrobial activity than the one-target QSAR models. Further, it revealed the importance of the partition coefficient (log P) followed by energies of the highest occupied molecular orbital (HOMO) and topological parameters, molecular connectivity indices (1χ, 3χ and 3χv) in describing the antimicrobial activity of substituted hydrazides.

UI MeSH Term Description Entries
D009281 Naphthalenes Two-ring crystalline hydrocarbons isolated from coal tar. They are used as intermediates in chemical synthesis, as insect repellents, fungicides, lubricants, preservatives, and, formerly, as topical antiseptics.
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000085 Acetates Derivatives of ACETIC ACID. Included under this heading are a broad variety of acid forms, salts, esters, and amides that contain the carboxymethane structure. Acetate,Acetic Acid Esters,Acetic Acids,Acids, Acetic,Esters, Acetic Acid
D000890 Anti-Infective Agents Substances that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection. Anti-Infective Agent,Anti-Microbial Agent,Antimicrobial Agent,Microbicide,Microbicides,Anti-Microbial Agents,Antiinfective Agents,Antimicrobial Agents,Agent, Anti-Infective,Agent, Anti-Microbial,Agent, Antimicrobial,Agents, Anti-Infective,Agents, Anti-Microbial,Agents, Antiinfective,Agents, Antimicrobial,Anti Infective Agent,Anti Infective Agents,Anti Microbial Agent,Anti Microbial Agents
D060326 Chemistry Techniques, Synthetic Methods used for the chemical synthesis of compounds. Included under this heading are laboratory methods used to synthesize a variety of chemicals and drugs. Inorganic Synthesis,Inorganic Synthesis Methods,Inorganic Synthesis Techniques,Methods of Inorganic Synthesis,Methods of Organic Synthesis,Methods of Peptide Synthesis,Organic Synthesis,Organic Synthesis Methods,Organic Synthesis Techniques,Peptide Synthesis Methods,Peptide Synthesis Techniques,Peptide Synthesis, Synthetic,Synthetic Chemistry Techniques,Synthetic Peptide Synthesis,Chemistry Technique, Synthetic,Inorganic Syntheses,Inorganic Synthesis Method,Inorganic Synthesis Technique,Method, Inorganic Synthesis,Method, Organic Synthesis,Method, Peptide Synthesis,Methods, Inorganic Synthesis,Methods, Organic Synthesis,Methods, Peptide Synthesis,Organic Syntheses,Organic Synthesis Technique,Peptide Syntheses, Synthetic,Peptide Synthesis Method,Peptide Synthesis Technique,Syntheses, Inorganic,Syntheses, Organic,Syntheses, Synthetic Peptide,Synthesis Method, Inorganic,Synthesis Method, Peptide,Synthesis Methods, Inorganic,Synthesis Methods, Peptide,Synthesis Technique, Inorganic,Synthesis Technique, Organic,Synthesis Technique, Peptide,Synthesis Techniques, Inorganic,Synthesis Techniques, Organic,Synthesis Techniques, Peptide,Synthesis, Inorganic,Synthesis, Organic,Synthesis, Synthetic Peptide,Synthetic Chemistry Technique,Synthetic Peptide Syntheses,Technique, Inorganic Synthesis,Technique, Organic Synthesis,Technique, Peptide Synthesis,Technique, Synthetic Chemistry,Techniques, Inorganic Synthesis,Techniques, Organic Synthesis,Techniques, Peptide Synthesis,Techniques, Synthetic Chemistry
D021281 Quantitative Structure-Activity Relationship A quantitative prediction of the biological, ecotoxicological or pharmaceutical activity of a molecule. It is based upon structure and activity information gathered from a series of similar compounds. Structure Activity Relationship, Quantitative,3D-QSAR,QSAR,QSPR Modeling,Quantitative Structure Property Relationship,3D QSAR,3D-QSARs,Modeling, QSPR,Quantitative Structure Activity Relationship,Quantitative Structure-Activity Relationships,Relationship, Quantitative Structure-Activity,Relationships, Quantitative Structure-Activity,Structure-Activity Relationship, Quantitative,Structure-Activity Relationships, Quantitative

Related Publications

Rakesh Narang, and Balasubramanian Narasimhan, and Sunil Sharma, and Erik De Clercq, and Christophe Pannecouque, and Jan Balzarini
September 2016, Molecules (Basel, Switzerland),
Rakesh Narang, and Balasubramanian Narasimhan, and Sunil Sharma, and Erik De Clercq, and Christophe Pannecouque, and Jan Balzarini
April 2012, Acta crystallographica. Section E, Structure reports online,
Rakesh Narang, and Balasubramanian Narasimhan, and Sunil Sharma, and Erik De Clercq, and Christophe Pannecouque, and Jan Balzarini
August 2005, Molecules (Basel, Switzerland),
Rakesh Narang, and Balasubramanian Narasimhan, and Sunil Sharma, and Erik De Clercq, and Christophe Pannecouque, and Jan Balzarini
December 2010, European journal of medicinal chemistry,
Rakesh Narang, and Balasubramanian Narasimhan, and Sunil Sharma, and Erik De Clercq, and Christophe Pannecouque, and Jan Balzarini
November 2008, European journal of medicinal chemistry,
Rakesh Narang, and Balasubramanian Narasimhan, and Sunil Sharma, and Erik De Clercq, and Christophe Pannecouque, and Jan Balzarini
March 2009, European journal of medicinal chemistry,
Rakesh Narang, and Balasubramanian Narasimhan, and Sunil Sharma, and Erik De Clercq, and Christophe Pannecouque, and Jan Balzarini
October 2011, Journal of enzyme inhibition and medicinal chemistry,
Rakesh Narang, and Balasubramanian Narasimhan, and Sunil Sharma, and Erik De Clercq, and Christophe Pannecouque, and Jan Balzarini
July 2002, European journal of medicinal chemistry,
Rakesh Narang, and Balasubramanian Narasimhan, and Sunil Sharma, and Erik De Clercq, and Christophe Pannecouque, and Jan Balzarini
June 2007, Bioorganic & medicinal chemistry,
Rakesh Narang, and Balasubramanian Narasimhan, and Sunil Sharma, and Erik De Clercq, and Christophe Pannecouque, and Jan Balzarini
March 2013, Acta crystallographica. Section E, Structure reports online,
Copied contents to your clipboard!